88%
OF DRUGS THAT ENTER THE CLINIC NEVER GAIN APPROVAL
Shift the possibilities

Targeted therapies, biomarker-driven insights, cutting-edge data sciences, and advanced clinical trial designs and implementation can all drive the likelihood of greater success. Let’s get started.

88%
OF DRUGS THAT ENTER THE CLINIC NEVER GAIN APPROVAL
Shift the possibilities

Targeted therapies, biomarker-driven insights, cutting-edge data sciences, and advanced clinical trial designs and implementation can all drive the likelihood of greater success. Let’s get started.

Precision is an accelerator of innovation, devoted to supporting the development of new treatments

As a precision medicine clinical research services organization, we have brought together new technologies, expertise and operational scale to help the life sciences improve the speed, cost and success rate of bringing life-changing therapies to patients.

42%
OF DRUGS APPROVED IN 2018 WERE BIOMARKER DRIVEN
42%
OF DRUGS APPROVED IN 2018 WERE BIOMARKER DRIVEN

Precision Convergence, the combined power of trials, translational sciences and data

As a precision medicine clinical research services organization, we have brought together new technologies, expertise and operational scale to help the life sciences improve the speed, cost and success rate of bringing life-changing therapies to patients.

2
YEARS FASTER AVERAGE APPROVAL TIME FOR PRECISION MEDICINE

Precision Convergence, the combined power of trials, labs and data sciences to drive faster clinical development

What sets us apart is the way we integrate clinical trial execution with deep scientific knowledge, laboratory expertise, and advanced data sciences. This is Precision Convergence: maximizing insights into patient biology and accelerating the pace of scientific discovery and approval.

Clinical Trial Services
  • First-in-human through regulatory approval global expertise
  • 2000+ dedicated professionals
  • Oncology, cell and gene therapy, rare and orphan disease
Specialty Lab Services
  • Full portfolio of specialty assays
  • Custom assays to full-scale GxP and CLIA validation
  • Global biospecimen and lab footprint
Data Sciences
  • Deeper biological insights enriched by data
  • Innovative analytics empower critical clinical development decisions
  • Operational visibility and management enabled by data
500+
CLINICAL TRIALS
35
OFFICES IN NORTH AMERICA, EUROPE AND ASIA-PACIFIC
2000+
DEDICATED PROFESSIONALS

“Targeted medicine is the way forward.”

Gyöngyi Hatvani
Senior CPM, Budapest

500+
CLINICAL TRIALS
35
OFFICES IN NORTH AMERICA, EUROPE AND ASIA-PACIFIC
2000+
DEDICATED PROFESSIONALS

“Targeted medicine is the way forward.”

Gyöngyi Hatvani
Senior CPM, Budapest

Our reputation is built on success in these areas

Oncology & Immuno-Oncology

Through 20+ years running successful oncology trials, we’ve developed a unique blend of proprietary technologies, flexible processes, and creative problem solving abilities that advance even the most challenging clinical development programs.

Rare & Orphan Disease

With experience built on 150+ orphan disease projects covering 80+ rare diseases, we know how to anticipate logistical and regulatory obstacles and craft bold solutions that drive rare disease development programs.

Cell & Gene Therapy

With team members who are global thought leaders in cell and gene therapy development, Precision brings together scientific, clinical and regulatory expertise that is advancing the development of these programs as well as oncolytic viruses, cancer vaccines and radiolabeled ligands.

Our novel approach impacts many areas of human health

Neurology

We combine advances in neurology biomarkers and biomarker detection technology for robust therapeutic development.

Autoimmune & Allergy

We support development programs with state-of-the-art immune monitoring solutions and immunogenicity testing expertise.

COVID-19

We are engaged in COVID-19 research with comprehensive solutions for all areas of therapeutic, vaccine, and diagnostic development.

Pediatric

Advanced clinical trial design expertise and sensitive biomarker detection technologies accelerate pediatric therapeutic development.

Companion Diagnostics

Our integrated clinical development, biomarker assay, regulatory strategy, and commercialization capabilities deliver unique value for CDx programs.

Precision covers the globe, supporting trials at every stage

From early development to regulatory approval, from sea to sea, Precision is a global partner to many of the most innovative life sciences companies in the world

68%
OF PII/PIII STUDIES ARE INTERNATIONAL
68%
OF PII/PIII STUDIES ARE INTERNATIONAL